Calvo Pinilla, E. M., Gubbins, S., Mertens, P., Ortego, J., & Castillo-Olivares, J. (2018). The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.
Citación estilo ChicagoCalvo Pinilla, Eva María, S. Gubbins, Peter Mertens, Javier Ortego, y J. Castillo-Olivares. The Immunogenicity of Recombinant Vaccines Based On Modified Vaccinia Ankara (MVA) Viruses Expressing African Horse Sickness Virus VP2 Antigens Depends On the Levels of Expressed VP2 Protein Delivered to the Host. 2018.
Cita MLACalvo Pinilla, Eva María, et al. The Immunogenicity of Recombinant Vaccines Based On Modified Vaccinia Ankara (MVA) Viruses Expressing African Horse Sickness Virus VP2 Antigens Depends On the Levels of Expressed VP2 Protein Delivered to the Host. 2018.